Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

ClinicalTrials.gov ID: NCT04625725

Public ClinicalTrials.gov record NCT04625725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of a single dose of AZD7442(× 2 IM injections) compared to placebo for the prevention of COVID-19.

Study identification

NCT ID
NCT04625725
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
5,197 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 21, 2020 (Actual)
Primary completion
Aug 16, 2022 (Actual)
Completion
Dec 8, 2023 (Actual)
Last update posted
Dec 31, 2024

2020 – 2023

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Research Site Birmingham Alabama 35215 —
Research Site Tempe Arizona 85284 —
Research Site Little Rock Arkansas 72205 —
Research Site Cerritos California 90703 —
Research Site Fresno California 93720 —
Research Site Garden Grove California 92844 —
Research Site Huntington Beach California 92647 —
Research Site Lancaster California 93534 —
Research Site Modesto California 95350 —
Research Site Victorville California 92394 —
Research Site Westminster California 92683 —
Research Site Hartford Connecticut 06112 —
Research Site Middlebury Connecticut 06762 —
Research Site Clearwater Florida 33756 —
Research Site Coral Springs Florida 33071 —
Research Site Hollywood Florida 33024 —
Research Site Lauderdale Lakes Florida 33313 —
Research Site Miami Florida 33125 —
Research Site Ormond Beach Florida 32174 —
Research Site Pompano Beach Florida 33064 —
Research Site Wesley Chapel Florida 33545 —
Research Site West Palm Beach Florida 33409 —
Research Site Atlanta Georgia 30328 —
Research Site Columbus Georgia 31904 —
Research Site Conyers Georgia 30094 —
Research Site Marietta Georgia 30060 —
Research Site Honolulu Hawaii 96859 —
Research Site Chicago Illinois 60607 —
Research Site Hazel Crest Illinois 60429 —
Research Site Quincy Illinois 62301 —
Research Site Evansville Indiana 47714 —
Research Site Noblesville Indiana 46060 —
Research Site Wichita Kansas 67205 —
Research Site Wichita Kansas 67214 —
Research Site Minneapolis Minnesota 55404 —
Research Site Minneapolis Minnesota 55435 —
Research Site St Louis Missouri 63141 —
Research Site Omaha Nebraska 68134 —
Research Site Las Vegas Nevada 89128 —
Research Site Albuquerque New Mexico 87109 —
Research Site Jamaica New York 11432 —
Research Site Ridgewood New York 11385 —
Research Site The Bronx New York 10461 —
Research Site Greensboro North Carolina 27410 —
Research Site Columbus Ohio 43213 —
Research Site Oklahoma City Oklahoma 73104 —
Research Site Summerville South Carolina 29485 —
Research Site Rapid City South Dakota 57701 —
Research Site Austin Texas 78751 —
Research Site El Paso Texas 79925 —
Research Site El Paso Texas 79935 —
Research Site Houston Texas 77054 —
Research Site San Antonio Texas 78215 —
Research Site San Antonio Texas 78251 —
Research Site Shenandoah Texas 77384 —
Research Site Sugar Land Texas 77479 —
Research Site Layton Utah 84041 —
Research Site Alexandria Virginia 22304 —
Research Site Chesapeake Virginia 23320 —
Research Site Tacoma Washington 98402 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04625725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 31, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04625725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →